Mon, 30 Apr 2012 07:30:28 -0700
Significantly higher costs led to the higher year-over-year loss.
Thu, 26 Apr 2012 04:00:00 -0700
Amylin Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2012.
Thu, 26 Apr 2012 09:14:05 -0700
Diabetes drug maker Amylin Pharmaceuticals Inc. said Thursday that sales of its new drug Bydureon totaled $6.9 million in the first quarter, missing analysts' estimates.
Mon, 30 Apr 2012 13:52:01 -0700
Fusilev sales dominate, but can they last?
Thu, 26 Apr 2012 06:23:35 -0700
Amylin Pharma Q1 Loss Widens
Fri, 27 Apr 2012 01:01:00 -0700
San Diego’s Websense reported better-than-expected revenue and earnings for its first quarter, thanks to strong sales of Triton Web security software sold to businesses.
